Northern Trust Corp Idera Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.01 - $1.58 $81 - $127	-81 Reduced 0.11%	74,267 $89,000
Q1 2021 May 12, 2021	BUY	$1.23 - $5.98 $24,634 - $119,767	20,028 Added 36.87%	74,348 $97,000
Q4 2020 Feb 11, 2021	SELL	$2.09 - $5.18 $5,900 - $14,623	-2,823 Reduced 4.94%	54,320 $199,000
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.68 $4,982 - $7,809	2,914 Added 5.37%	57,143 $122,000
Q2 2020 Aug 14, 2020	SELL	$1.23 - $2.12 $167 - $288	-136 Reduced 0.25%	54,229 $97,000
Q1 2020 May 14, 2020	BUY	$1.06 - $2.15 $3,918 - $7,948	3,697 Added 7.3%	54,365 $72,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $2.79 $16,116 - $31,010	-11,115 Reduced 17.99%	50,668 $92,000
Q3 2019 Nov 13, 2019	SELL	$2.12 - $3.31 $362,286 - $565,645	-170,890 Reduced 73.45%	61,783 $179,000
Q2 2019 Aug 13, 2019	SELL	$2.37 - $3.97 $20,787 - $34,820	-8,771 Reduced 3.63%	232,673 $622,000
Q1 2019 May 13, 2019	SELL	$2.33 - $3.79 $4,084 - $6,643	-1,753 Reduced 0.72%	241,444 $616,000
Q4 2018 Feb 12, 2019	SELL	$2.77 - $9.38 $1,149 - $3,892	-415 Reduced 0.17%	243,197 $674,000
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $1.35 Million - $2.77 Million	243,612 New	243,612 $2.17 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.